The takeaway
Rentokil Initial PLC shows a moderate seasonal pattern over 10 years of data — strongest in July (+7.2%) and softest in November (+1.2%).
Right now
In July, the stock has risen 90% of years, averaging +7.2%, about +5.1 pts better than the S&P 500.
The full picture
Rentokil Initial PLC's most dependable month has been July, higher in 9 of 10 years; November has been its least reliable, up just 30% of the time.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Win rate % | ||||||||||||
| Median return % | ||||||||||||
| 2025 | ||||||||||||
| 2024 | ||||||||||||
| 2023 | ||||||||||||
| 2022 | ||||||||||||
| 2021 | ||||||||||||
| 2020 | ||||||||||||
| 2019 | ||||||||||||
| 2018 | ||||||||||||
| 2017 | ||||||||||||
| 2016 |
Month by month
The stock's clearest edge over the S&P 500 lands in July (+5.1 pts); it has trailed the market most in September (−2.4 pts).
“vs S&P” is Rentokil Initial PLC’s average for a month minus the S&P 500’s average for that same month — isolating Rentokil Initial PLC’s own seasonal edge from broad market drift.
Reality check
Over the last 5 years, July has closed higher 100% of the time versus 90% across the last 10 years — the pattern is holding.
Figures are the typical (median) July return and how often it rose — the last 5 years versus the last 10(the heatmap’s default window). This verdict stays anchored to that 10-year window even if you zoom the chart, so it never disagrees with the badges above.
In plain English
Dependability is the through-line here. July stands out, higher in 9 of 10 Julys, but it heads a clutch of months that pull the year reliably upward.
Its average (+7.2%) and median (+7.3%) land within a hair of each other — the tell of steady, year-after-year gains rather than one outlier doing the work. Crucially, the gain is the stock's own rather than a rising tide's: July has cleared the S&P 500 by +5.1 points above the index. That consistency sets it apart from the field, where the average stock manages July only about 61% of the time.
The strength clusters rather than stands alone — February–July forms a firm stretch that carries much of the year. On the other side of the ledger, November is the year's low point, though even there the stock has stayed positive on average (+1.2%), a sign every month leans up, and the edge isn't year-round — the stock has trailed the S&P 500 in September, January, and November. Its roughest month on record was a −28.8% October in 2023 — a reminder of how hard even a seasonal name can fall.
July has now closed higher 7 years running. Reassuringly, the tendency has held its shape: the recent five years still track the years behind them.
The takeaway is less about when to buy than what to expect: July aside, the stock's months offer little reliable tilt.
Short answers on the stock's best month (July), its worst (November), and whether it really trades seasonally.
Yes, to a moderate degree. Since 2016 its best month (July, +7.2%) has run well ahead of its worst (November, +1.2%) — the heatmap above shows how steady that gap has been year to year.
July has been the strongest, averaging +7.2% and closing higher in 9 of 10 years since 2016.
It's the weakest month, but it has still averaged a small gain (+1.2%) — quiet rather than genuinely bad.
Explore
These names have the strongest July track records on record — a starting point for comparison.
Before you trade